Melissa A. Starovasnik, Director at Twist Bioscience Corp (TWST), sold 1,000 shares at $51.00 ($51K) on 2026-04-01, disclosed to the SEC on 2026-04-03.
Scheduled sale ($51k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TWST | SELL | 2026-04-29 | $31K | — | Filing → |
| TWST | SELL | 2023-02-13 | $46K | — | Filing → |